| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 12/13/2001 | CA2411542A1 Encapsulation of polynucleotides and drugs into targeted liposomes |
| 12/13/2001 | CA2411473A1 Compositions, kits, and methods for identification and modulation of type i diabetes |
| 12/13/2001 | CA2411285A1 Combined preparation for the treatment of neoplasic diseases |
| 12/13/2001 | CA2411101A1 A gene encoding a multidrug resistance human p-glycoprotein homologue on chromosome 7p15-21 and uses thereof |
| 12/13/2001 | CA2411017A1 Epididymis-specific proteins with fibronectin type ii modules |
| 12/13/2001 | CA2410512A1 Recombinant aav vectors for gene therapy of obesity |
| 12/13/2001 | CA2410188A1 Non-agonistic antibodies to human gp39, compositions containing, and therapeutic use thereof |
| 12/13/2001 | CA2410052A1 Delivery systems for bioactive agents |
| 12/13/2001 | CA2409392A1 Intracellular signaling proteins |
| 12/12/2001 | EP1162273A1 Recombinant DNA vectors for gene therapy |
| 12/12/2001 | EP1162272A2 Generation of immune responses to prostate-specific antigen (SPA) |
| 12/12/2001 | EP1162265A2 Human PEM as a target for fertility control and Alzheimer therapy |
| 12/12/2001 | EP1162263A1 Nucleozymes |
| 12/12/2001 | EP1162206A2 Peptide nucleic acids |
| 12/12/2001 | EP1161549A2 Retrovirus producing cells utilizing a high multiplicity of transduction |
| 12/12/2001 | EP1161548A2 Recombinant protein production in a human cell using sequences encoding adenovirus e1 protein |
| 12/12/2001 | EP1161547A1 Intravascular delivery of non-viral nucleic acid |
| 12/12/2001 | EP1161534A1 Differential expression of organellar gene products |
| 12/12/2001 | EP1161524A2 CELLS COEXPRESSING AN AMYLOID PRECURSOR PROTEIN AND AN $g(a)-SECRETASE AND THEIR USES IN TEST METHODS AND DIAGNOSTICS |
| 12/12/2001 | EP1161521A2 Transplantation of haematopoietic cells |
| 12/12/2001 | EP1161454A2 Peptides with anti-angiogenic activity |
| 12/12/2001 | EP1161448A1 49 human secreted proteins |
| 12/12/2001 | EP1161447A1 50 human secreted proteins |
| 12/12/2001 | EP1161444A1 A novel inhibitor of programmed cell death |
| 12/12/2001 | EP1161442A2 Exocytosis pathway proteins and methods of use |
| 12/12/2001 | EP1161439A1 Xylo-lna analogues |
| 12/12/2001 | EP1161262A1 SURFACE LOCALIZED COLLIGIN/HsP47 IN CARCINOMA CELLS |
| 12/12/2001 | EP1161147A1 Peptide mimics useful for treating disease |
| 12/12/2001 | EP1161142A1 Methods for culturing fluid-filled sensory organs |
| 12/12/2001 | EP0783586B1 An attenuated vaccination and gene-transfer virus, a method to make the virus and a pharmaceutical composition comprising the virus |
| 12/12/2001 | EP0766570B1 Methods for treating respiratory disease |
| 12/12/2001 | CN1326511A Systemic viral/ligand gene delivery system and gene therapy |
| 12/12/2001 | CN1326509A MOraxella catarrhalis ABSB034 polypeptides and uses thereof |
| 12/12/2001 | CN1326508A Polynucleotides and polypeptides BASB033 from neisseria meningitidis and their uses |
| 12/12/2001 | CN1326506A Use of specific hybrid promoters for controlling tissue expression |
| 12/12/2001 | CN1326467A Expression and export of angiostation and endostatin as immunofusins |
| 12/12/2001 | CN1326365A Nucleic acid transporters and medicinal compositions for gene therapy |
| 12/12/2001 | CN1326361A Methods for detecting, preventing, and treating renal disorders by modulating, regulating and inhibiting connective tissue growth factor |
| 12/12/2001 | CN1326360A Use of enterobacterium protein OMPA for specific targeting towards antigen-presening cells |
| 12/12/2001 | CN1326358A Method of DNA vaccination |
| 12/11/2001 | US6330472 Prophylactic and therapeutic treatment of the ductal epithelium for a mammary gland for cancer |
| 12/11/2001 | US6329501 Methods and compositions for targeting compounds to muscle |
| 12/11/2001 | US6329348 Method of inducing angiogenesis |
| 12/11/2001 | US6329203 Antisense modulation of glioma-associated oncogene-1 expression |
| 12/11/2001 | US6329201 An rna vector having alphavirus transcription sequences, a promoter and untranslated region from subgenomic venezuelan equine encephalitis, and alphavirus structural protein sequences; for directing expression of heterologous genes |
| 12/11/2001 | US6329199 A vector resistant to inactivation by human serum, produced in cells containing retroviral envelope protein sequence from feline endogenous virus, long terminal repeats sequences, signal and packaging sequences; for effective gene therapy |
| 12/11/2001 | US6329190 Targetting adenovirus with use of constrained peptide motifs |
| 12/11/2001 | US6328978 Methods for the treatment of immunologically-mediated skin disorders |
| 12/11/2001 | US6328971 MAGE-1 derived nona peptides, and compositions thereof |
| 12/11/2001 | US6328958 Deleted adenovirus vectors and methods of making and administering the same |
| 12/11/2001 | US6328957 Heat shock proteins and the treatment of tumors |
| 12/11/2001 | US6328956 Pharmaceutical composition for the treatment or prevention of a malignant tumor |
| 12/11/2001 | US6328762 Prosthetic grafts |
| 12/11/2001 | CA2136094C Methods and compositions for increasing the sensitivity of a cell to a dna damaging agent |
| 12/11/2001 | CA2066053C Recombinant retroviruses delivering vector constructs to target cells |
| 12/06/2001 | WO2001092892A2 Methods to identify compounds that modulate rage |
| 12/06/2001 | WO2001092891A2 Regulating lipid levels via the zmax1 or hbm gene |
| 12/06/2001 | WO2001092877A2 Method of identifying and/or isolating stem cells |
| 12/06/2001 | WO2001092580A2 Lyophilizable and enhanced compacted nucleic acids |
| 12/06/2001 | WO2001092578A2 Reagents and methods for identifying and modulating expression of genes regulated by retinoids |
| 12/06/2001 | WO2001092567A2 Novel target genes for diseases of the heart |
| 12/06/2001 | WO2001092565A2 Diagnosis of diseases associated dna transcription by means of assessing the methylation status of genes associated with dna transcription |
| 12/06/2001 | WO2001092562A2 Inhibiting retroviral integration by targeting the atm pathway |
| 12/06/2001 | WO2001092552A2 Method for the purification of alphavirus replicon particles |
| 12/06/2001 | WO2001092551A2 Duplexed parvovirus vectors |
| 12/06/2001 | WO2001092550A2 Methods and compositions for efficient gene transfer using transcomplementary vectors |
| 12/06/2001 | WO2001092549A2 Method and composition for targeting an adenoviral vector |
| 12/06/2001 | WO2001092548A2 Vaccine and gene therapy vector and methods of use thereof |
| 12/06/2001 | WO2001092547A2 Modified bovine adenovirus having altered tropism |
| 12/06/2001 | WO2001092543A2 Improved methods of transfection |
| 12/06/2001 | WO2001092542A2 Integrin-targeting vectors having enhanced transfection activity |
| 12/06/2001 | WO2001092530A1 Nucleic acid molecule comprising a nucleic acid sequence coding for an sdf-1 gamma chemokine, a neuropeptide precursor or at least one neuropeptide |
| 12/06/2001 | WO2001092528A2 Method of diagnosing, monitoring, staging, imaging and treating colon cancer |
| 12/06/2001 | WO2001092526A1 Human kcnq5 potassium channel, methods and compositions thereof |
| 12/06/2001 | WO2001092513A1 METHODS FOR MEDIATING GENE SUPPRESION BY USING FACTORS THAT ENHANCE RNAi |
| 12/06/2001 | WO2001092512A2 Targeted chromosomal genomic alterations in plants using modified single stranded oligonucleotides |
| 12/06/2001 | WO2001092508A1 Pseudo-type retrovirus vector containing membrane protein having hemagglutinin activity |
| 12/06/2001 | WO2001092470A2 Dna expression vectors and methods of use |
| 12/06/2001 | WO2001092330A2 Use of acrp30 globular head to promote increases in muscle mass and muscle differentiation |
| 12/06/2001 | WO2001092310A2 Regulation of human transketolase-like enzyme |
| 12/06/2001 | WO2001092307A2 Therapeutic compounds for ovarian cancer |
| 12/06/2001 | WO2001092306A2 Therapeutic compounds for ovarian cancer |
| 12/06/2001 | WO2001092299A2 Adenovirus particles with mutagenized fiber proteins |
| 12/06/2001 | WO2001092294A2 Therapeutic anti-melanoma compounds |
| 12/06/2001 | WO2001091816A1 Delivery systems comprising biocompatible and bioerodable membranes |
| 12/06/2001 | WO2001091803A2 Methods and compounds for controlled release of recombinant parvovirus vectors |
| 12/06/2001 | WO2001091802A1 Chimeric viral vectors for gene therapy |
| 12/06/2001 | WO2001091801A2 Methods of transducing neural cells using lentivirus vectors |
| 12/06/2001 | WO2001091800A1 Ubiquitin promoter in vectors for gene therapy in respiratory tract |
| 12/06/2001 | WO2001091799A2 Medicament for the treatment of immune reactions in the eye |
| 12/06/2001 | WO2001091789A2 Combination of a mutant herpes virus and a chemotherapeutic agent for the treatment of cancer |
| 12/06/2001 | WO2001091787A1 Complexes of alpha (2) macroglobulin and antigenic molecules for immunotherapy |
| 12/06/2001 | WO2001091739A2 Compositions and methods for treating neoplastic disease using chemotherapy and radiation sensitizers |
| 12/06/2001 | WO2001091728A2 Nanoemulsion formulations |
| 12/06/2001 | WO2001091725A2 Biologically useful polyphosphates |
| 12/06/2001 | WO2001091699A2 Compositions and methods for identifying agents which modulate pten function and pi-3 kinase pathways |
| 12/06/2001 | WO2001055387A8 Nucleic acids, proteins, and antibodies |
| 12/06/2001 | WO2001055313A8 Nucleic acids, proteins, and antibodies |
| 12/06/2001 | WO2001053351A3 Apoptin bindendes protein |
| 12/06/2001 | WO2001046392A3 Homologues of human heparanase and splice variants thereof |